they may become an important component of integrated cardiovascular risk reduction strategies in people living with overweight or obesity. GLP-1 medications were originally developed to help manage type 2 diabetes
Schweizer, A., Dejager, S., Foley, J
Sticking with the product through the first few weeks allows your digestive system to settle into a new rhythm
While not a heart disease risk predictor, these results help PlexusDx clinicians choose whether semaglutide, tirzepatide, or GLP-Squared best matches your biology for optimal cardiovascular and metabolic benefit
Constipation is classified as a syndrome and may include the infrequent (fewer than three a week) or difficult passage of stool, hardness of stool, and/or a feeling of incomplete evacuation